APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
| Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
| Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
| Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
| Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
| Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
| GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
| Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
| Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
| Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |